Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win

Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win

Submitted by admin on July 19, 2024 - 11:55am
Source: 
Clinical Trials Arena
News Tags: 
Bayer
clinical trials
Nubeqa
prostate cancer
Headline: 
Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win
snippet: 

The Phase III trial evaluating Nubeqa in patients with metastatic hormone-sensitive prostate cancer met its primary endpoint.

Do Not Allow Advertisers to Use My Personal information